Home › COPD › Oklahoma › Tulsa
COPD clinical trials in Tulsa, OK
4 studies for COPD are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Tulsa
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Layrek Clinical Research- Site Number : 8400066, Tulsa
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
- Research Site, Tulsa
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RecruitingPhase 3
- Research Site, Tulsa
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA23 studies
- Miami, FL18 studies
- Birmingham, AL17 studies
- Boston, MA17 studies
- Orlando, FL15 studies
- Houston, TX15 studies
- Baltimore, MD14 studies
- Chicago, IL14 studies
- Dallas, TX12 studies
- Pittsburgh, PA12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in Tulsa
- Heart Failure10 studies
- Overweight6 studies
- Obesity5 studies
- Melanoma5 studies
- Ischemic Stroke5 studies
- Parkinson's Disease4 studies
- Aortic Valve Stenosis4 studies
- Cervical Cancer4 studies
- Breast Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Depression4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.